{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:52:08Z","timestamp":1791287528847,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sappani Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Steroid 5 alpha-reductase 3-related congenital disorder of glycosylation (SRD5A3-CDG) is a rare inherited disease characterized by neurological dysfunction, including ataxia, as well as developmental and visual impairments, with no approved treatments. The disease is caused by defects in dolichol biosynthesis, a pathway essential for protein glycosylation. However, the lack of suitable in vivo models has limited both mechanistic insight and therapeutic development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We generated a\n                      <jats:italic>Caenorhabditis elegans<\/jats:italic>\n                      model carrying a patient-relevant loss-of-function mutation and performed a motility-based phenotypic drug repurposing screen to identify compounds that improve disease-relevant phenotypes. Lead compounds were evaluated in behavioral, neuronal, and metabolomic assays in worms and in fibroblasts from four individuals with SRD5A3-CDG.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here we show that SRD5A3-deficient worms exhibit developmental delay, neuronal dysfunction, and metabolic alterations consistent with dysregulation of the mevalonate pathway. The screen identifies multiple classes of compounds that improve motility, including the cholesterol-lowering drug atorvastatin. Atorvastatin improves multiple disease-relevant phenotypes in the worm model. In patient-derived fibroblasts, treatment partially restores the balance between polyprenol and dolichol, which is disrupted in SRD5A3-CDG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings establish an in vivo model of SRD5A3-CDG and identify modulation of the mevalonate pathway as a potential therapeutic strategy. The results support further investigation of atorvastatin as a repurposed treatment and demonstrate an approach for combining model organism screening with human cell validation to accelerate rare disease drug discovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01791-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:57:13Z","timestamp":1785319033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8975-983X","authenticated-orcid":false,"given":"Hiba","family":"Daghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Kee","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Maios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasantha","family":"Ranatunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Samarut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan O.","family":"Perlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-6127","authenticated-orcid":false,"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-2445","authenticated-orcid":false,"given":"J. Alex","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2350-3073","authenticated-orcid":false,"given":"Kristin A.","family":"Kantautas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108476","volume":"142","author":"BG Ng","year":"2024","unstructured":"Ng, B. G., Freeze, H. H., Himmelreich, N., Blau, N. & Ferreira, C. R. Clinical and biochemical footprints of congenital disorders of glycosylation: proposed nosology. Mol. Genet. Metab. 142, 108476 (2024).","journal-title":"Mol. Genet. Metab."},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1002\/ajmg.a.37875","volume":"170","author":"PG Wheeler","year":"2016","unstructured":"Wheeler, P. G. et al. SRD5A3-CDG: expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features. Am. J. Med. Genet. A 170, 3165\u20133171 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"1791_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01657-5","volume":"16","author":"A Bogda\u0144ska","year":"2021","unstructured":"Bogda\u0144ska, A. et al. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up. Orphanet J. Rare Dis. 16, 17 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ajmg.a.62065","volume":"185","author":"I Ben Ayed","year":"2021","unstructured":"Ben Ayed, I. et al. SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition. Am. J. Med. Genet. A 185, 1081\u20131090 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mdc3.13627","volume":"10","author":"VV Holla","year":"2023","unstructured":"Holla, V. V. et al. Mirror movements and dystonia in SRD5A3-related congenital disorders of glycosylation: expanding the phenotypic and genotypic spectrum. Mov. Disord. Clin. Pract. 10, 510\u2013513 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41431-020-0647-3","volume":"28","author":"J Jaeken","year":"2020","unstructured":"Jaeken, J., Lefeber, D. J. & Matthijs, G. SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card. Eur. J. Hum. Genet. 28, 1297\u20131300 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"1791_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.737094","volume":"12","author":"N Kamarus Jaman","year":"2021","unstructured":"Kamarus Jaman, N. et al. SRD5A3-CDG: emerging phenotypic features of an ultrarare CDG subtype. Front Genet 12, 737094 (2021).","journal-title":"Front Genet"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.14712\/fb2019065030134","volume":"65","author":"B Kousal","year":"2019","unstructured":"Kousal, B. et al. Review of SRD5A3 disease-causing sequence variants and ocular findings in steroid 5\u03b1-reductase type 3 congenital disorder of glycosylation, and a detailed new case. Folia Biol. (Praha) 65, 134\u2013141 (2019).","journal-title":"Folia Biol. (Praha)"},{"key":"1791_CR9","first-page":"369","volume":"10","author":"Y Nakayama","year":"1984","unstructured":"Nakayama, Y., Numata, A., Kubota, K. & Ozaki, T. Dental anomalies among primary school pupils. II. Degenerative upper lateral incisor. Nichidai Koko Kagaku 10, 369\u2013373 (1984).","journal-title":"Nichidai Koko Kagaku"},{"key":"1791_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104492","volume":"65","author":"M Rieger","year":"2022","unstructured":"Rieger, M. et al. SRD5A3-CDG: twins with an intragenic tandem duplication. Eur. J. Med. Genet. 65, 104492 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"1791_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06314-1","volume":"16","author":"S Sabry","year":"2023","unstructured":"Sabry, S., Eissa, N. R. & Zaki, M. S. Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation. BMC Res. Notes 16, 53 (2023).","journal-title":"BMC Res. Notes"},{"key":"1791_CR12","doi-asserted-by":"publisher","unstructured":"Tachibana, N. et al. Maternal uniparental isodisomy of chromosome 4 and 8 in patients with retinal dystrophy: SRD5A3-congenital disorders of glycosylation and RP1-related retinitis pigmentosa. Genes 13, https:\/\/doi.org\/10.3390\/genes13020359 (2022).","DOI":"10.3390\/genes13020359"},{"key":"1791_CR13","doi-asserted-by":"publisher","unstructured":"Daescu, V., Horton, D. & Goodspeed, K. Characterization of the SRD5A3-CDG clinical spectrum. J. Inborn Errors Metab. Screen. https:\/\/doi.org\/10.1590\/2326-4594-jiems-2022-0010 (2023).","DOI":"10.1590\/2326-4594-jiems-2022-0010"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-011-9301-0","volume":"34","author":"V Cantagrel","year":"2011","unstructured":"Cantagrel, V. & Lefeber, D. J. From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases. J. Inherit. Metab. Dis. 34, 859\u2013867 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2010.06.001","volume":"142","author":"V Cantagrel","year":"2010","unstructured":"Cantagrel, V. et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 142, 203\u2013217 (2010).","journal-title":"Cell"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/glycob\/cwp136","volume":"19","author":"WB Struwe","year":"2009","unstructured":"Struwe, W. B. et al. Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci. Glycobiology 19, 1554\u20131562 (2009).","journal-title":"Glycobiology"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.cell.2024.04.041","volume":"187","author":"MP Wilson","year":"2024","unstructured":"Wilson, M. P. et al. A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis. Cell 187, 3585\u20133601.e3522 (2024).","journal-title":"Cell"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10545-014-9760-1","volume":"38","author":"A Buczkowska","year":"2015","unstructured":"Buczkowska, A., Swiezewska, E. & Lefeber, D. J. Genetic defects in dolichol metabolism. J. Inherit. Metab. Dis. 38, 157\u2013169 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1791_CR19","doi-asserted-by":"publisher","unstructured":"Labarre, A., Tossing, G., Maios, C., Doyle, J. J. & Parker, J. A. A single copy transgenic mutant FUS strain reproduces age-dependent ALS phenotypes in C. elegans. MicroPubl Biol. https:\/\/doi.org\/10.17912\/micropub.biology.000473 (2021).","DOI":"10.17912\/micropub.biology.000473"},{"key":"1791_CR20","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"1791_CR21","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1111\/j.1742-4658.2005.04945.x","volume":"272","author":"SF Altschul","year":"2005","unstructured":"Altschul, S. F. et al. Protein database searches using compositionally adjusted substitution matrices. FEBS J. 272, 5101\u20135109 (2005).","journal-title":"FEBS J."},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2023","unstructured":"Paysan-Lafosse, T. et al. InterPro in 2022. Nucleic Acids Res. 51, D418\u2013d427 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.14348\/molcells.2017.0017","volume":"40","author":"HH Park","year":"2017","unstructured":"Park, H. H., Jung, Y. & Lee, S. V. Survival assays using Caenorhabditis elegans. Mol. Cells 40, 90\u201399 (2017).","journal-title":"Mol. Cells"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/gerona\/glw248","volume":"72","author":"JA Rollins","year":"2017","unstructured":"Rollins, J. A., Howard, A. C., Dobbins, S. K., Washburn, E. H. & Rogers, A. N. Assessing Health Span in Caenorhabditis elegans: lessons from short-lived mutants. J. Gerontol. A Biol. Sci. Med. Sci. 72, 473\u2013480 (2017).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1534\/genetics.115.176099","volume":"200","author":"AK Corsi","year":"2015","unstructured":"Corsi, A. K., Wightman, B. & Chalfie, M. A transparent window into biology: a primer on caenorhabditis elegans. Genetics 200, 387\u2013407 (2015).","journal-title":"Genetics"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceb.2016.03.021","volume":"41","author":"N Cherepanova","year":"2016","unstructured":"Cherepanova, N., Shrimal, S. & Gilmore, R. N-linked glycosylation and homeostasis of the endoplasmic reticulum. Curr. Opin. Cell Biol. 41, 57\u201365 (2016).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1791_CR27","doi-asserted-by":"publisher","first-page":"68191","DOI":"10.18632\/oncotarget.19277","volume":"8","author":"P Guha","year":"2017","unstructured":"Guha, P., Kaptan, E., Gade, P., Kalvakolanu, D. V. & Ahmed, H. Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1. Oncotarget 8, 68191\u201368207 (2017).","journal-title":"Oncotarget"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","volume":"490","author":"CM Oslowski","year":"2011","unstructured":"Oslowski, C. M. & Urano, F. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol. 490, 71\u201392 (2011).","journal-title":"Methods Enzymol."},{"key":"1791_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82466-z","volume":"11","author":"SKB Taylor","year":"2021","unstructured":"Taylor, S. K. B. et al. C. elegans electrotaxis behavior is modulated by heat shock response and unfolded protein response signaling pathways. Sci. Rep. 11, 3115 (2021).","journal-title":"Sci. Rep."},{"key":"1791_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/39908","volume":"389","author":"SL McIntire","year":"1997","unstructured":"McIntire, S. L., Reimer, R. J., Schuske, K., Edwards, R. H. & Jorgensen, E. M. Identification and characterization of the vesicular GABA transporter. Nature 389, 870\u2013876 (1997).","journal-title":"Nature"},{"key":"1791_CR31","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1523\/JNEUROSCI.4384-12.2013","volume":"33","author":"HA Petrash","year":"2013","unstructured":"Petrash, H. A., Philbrook, A., Haburcak, M., Barbagallo, B. & Francis, M. M. ACR-12 ionotropic acetylcholine receptor complexes regulate inhibitory motor neuron activity in Caenorhabditis elegans. J. Neurosci. 33, 5524\u20135532 (2013).","journal-title":"J. Neurosci."},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/nprot.2006.281","volume":"1","author":"TR Mahoney","year":"2006","unstructured":"Mahoney, T. R., Luo, S. & Nonet, M. L. Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat. Protoc. 1, 1772\u20131777 (2006).","journal-title":"Nat. Protoc."},{"key":"1791_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/12160","volume":"2","author":"JE Richmond","year":"1999","unstructured":"Richmond, J. E. & Jorgensen, E. M. One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat. Neurosci. 2, 791\u2013797 (1999).","journal-title":"Nat. Neurosci."},{"key":"1791_CR34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ymgme.2011.12.017","volume":"105","author":"JE Gr\u00fcndahl","year":"2012","unstructured":"Gr\u00fcndahl, J. E. et al. Life with too much polyprenol: polyprenol reductase deficiency. Mol. Genet Metab. 105, 642\u2013651 (2012).","journal-title":"Mol. Genet Metab."},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ana.26245","volume":"90","author":"AN Ligezka","year":"2021","unstructured":"Ligezka, A. N. et al. Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications. Ann. Neurol. 90, 887\u2013900 (2021).","journal-title":"Ann. Neurol."},{"key":"1791_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101056","volume":"4","author":"S Radenkovic","year":"2023","unstructured":"Radenkovic, S. et al. Tracer metabolomics reveals the role of aldose reductase in glycosylation. Cell Rep. Med 4, 101056 (2023).","journal-title":"Cell Rep. Med"},{"key":"1791_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1476-511X-10-243","volume":"10","author":"M Rauthan","year":"2011","unstructured":"Rauthan, M. & Pilon, M. The mevalonate pathway in C. elegans. Lipids Health Dis. 10, 243 (2011).","journal-title":"Lipids Health Dis."},{"key":"1791_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jimd.12286","volume":"44","author":"R Altassan","year":"2021","unstructured":"Altassan, R. et al. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): diagnosis, follow-up, and management. J. Inherit. Metab. Dis. 44, 148\u2013163 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1791_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cca.2015.02.008","volume":"444","author":"R Choi","year":"2015","unstructured":"Choi, R. et al. Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations: a congenital disorder of glycosylation mimicking glycogen storage disease. Clin. Chim. Acta 444, 50\u201353 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"1791_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.intimp.2017.01.020","volume":"44","author":"R Letkemann","year":"2017","unstructured":"Letkemann, R. et al. Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib. Int. Immunopharmacol. 44, 216\u2013225 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"1791_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113883","volume":"43","author":"S Radenkovic","year":"2024","unstructured":"Radenkovic, S. et al. Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models. Cell Rep. 43, 113883 (2024).","journal-title":"Cell Rep."},{"key":"1791_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2023.01.004","volume":"257","author":"B Balakrishnan","year":"2023","unstructured":"Balakrishnan, B. et al. AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG). Transl. Res. 257, 1\u201314 (2023).","journal-title":"Transl. Res."},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.cmet.2021.05.003","volume":"33","author":"RC Sun","year":"2021","unstructured":"Sun, R. C. et al. Brain glycogen serves as a critical glucosamine cache required for protein glycosylation. Cell Metab. 33, 1404\u20131417.e1409 (2021).","journal-title":"Cell Metab."},{"key":"1791_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","volume":"5","author":"MM Adeva-Andany","year":"2016","unstructured":"Adeva-Andany, M. M., Gonz\u00e1lez-Luc\u00e1n, M., Donapetry-Garc\u00eda, C., Fern\u00e1ndez-Fern\u00e1ndez, C. & Ameneiros-Rodr\u00edguez, E. Glycogen metabolism in humans. BBA Clin. 5, 85\u2013100 (2016).","journal-title":"BBA Clin."},{"key":"1791_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15868","volume":"8","author":"I Gusarov","year":"2017","unstructured":"Gusarov, I. et al. Glycogen controls Caenorhabditis elegans lifespan and resistance to oxidative stress. Nat. Commun. 8, 15868 (2017).","journal-title":"Nat. Commun."},{"key":"1791_CR46","first-page":"Cd008226","volume":"2015","author":"SP Adams","year":"2015","unstructured":"Adams, S. P., Tsang, M. & Wright, J. M. Lipid-lowering efficacy of atorvastatin. Cochrane Database Syst. Rev. 2015, Cd008226 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1791_CR47","doi-asserted-by":"crossref","unstructured":"Feldman, F. et al. Efficacy of polyphenols in the management of dyslipidemia: a focus on clinical studies. Nutrients 13, 672 (2021).","DOI":"10.3390\/nu13020672"},{"key":"1791_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.advnut.2023.01.002","volume":"14","author":"T Kiyimba","year":"2023","unstructured":"Kiyimba, T. et al. Efficacy of dietary polyphenols from whole foods and purified food polyphenol extracts in optimizing cardiometabolic health: a meta-analysis of randomized controlled trials. Adv. Nutr. 14, 270\u2013282 (2023).","journal-title":"Adv. Nutr."},{"key":"1791_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202001019","volume":"65","author":"A Micek","year":"2021","unstructured":"Micek, A., Godos, J., Del Rio, D., Galvano, F. & Grosso, G. Dietary flavonoids and cardiovascular disease: a comprehensive dose-response meta-analysis. Mol. Nutr. Food Res. 65, e2001019 (2021).","journal-title":"Mol. Nutr. Food Res."},{"key":"1791_CR50","first-page":"4943","volume":"9","author":"B Islam","year":"2015","unstructured":"Islam, B., Sharma, C., Adem, A., Aburawi, E. & Ojha, S. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking. Drug Des. Dev. Ther. 9, 4943\u20134951 (2015).","journal-title":"Drug Des. Dev. Ther."},{"key":"1791_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jcb.25608","volume":"118","author":"S Suganya","year":"2017","unstructured":"Suganya, S., Nandagopal, B. & Anbarasu, A. Natural inhibitors of HMG-CoA reductase-an insilico approach through molecular docking and simulation studies. J. Cell. Biochem. 118, 52\u201357 (2017).","journal-title":"J. Cell. Biochem."},{"key":"1791_CR52","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1099\/mic.0.000636","volume":"164","author":"R Howlett","year":"2018","unstructured":"Howlett, R., Anttonen, K., Read, N. & Smith, M. C. M. Disruption of the GDP-mannose synthesis pathway in Streptomyces coelicolor results in antibiotic hyper-susceptible phenotypes. Microbiology 164, 614\u2013624 (2018).","journal-title":"Microbiology"},{"key":"1791_CR53","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1105\/tpc.111.083634","volume":"23","author":"N Jadid","year":"2011","unstructured":"Jadid, N. et al. Dolichol phosphate mannose synthase 1 mediates the biogenesis of isoprenyl-linked glycans and influences development, stress response, and ammonium hypersensitivity in Arabidopsis. Plant Cell 23, 1985\u20132005 (2011).","journal-title":"Plant Cell"},{"key":"1791_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-030-27480-1_2","volume":"23","author":"MK Brewer","year":"2019","unstructured":"Brewer, M. K. & Gentry, M. S. Brain Glycogen structure and its associated proteins: past, present and future. Adv. Neurobiol. 23, 17\u201381 (2019).","journal-title":"Adv. Neurobiol."},{"key":"1791_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2012.12.002","volume":"108","author":"B Sun","year":"2013","unstructured":"Sun, B. et al. Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III. Mol. Genet. Metab. 108, 145\u2013147 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"1791_CR56","doi-asserted-by":"crossref","unstructured":"Garapati, K. et al. N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. Glycobiology 34, cwae076 (2024).","DOI":"10.1093\/glycob\/cwae076"},{"key":"1791_CR57","doi-asserted-by":"crossref","unstructured":"Iyer, S. et al. Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches. Dis Model. Mech. 12, dmm040576 (2019).","DOI":"10.1242\/dmm.040576"},{"key":"1791_CR58","doi-asserted-by":"crossref","unstructured":"Iyer, S. et al. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Dis. Model. Mech. 12, dmm040584 (2019).","DOI":"10.1101\/626697"},{"key":"1791_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10545-016-0010-6","volume":"40","author":"LG Riley","year":"2017","unstructured":"Riley, L. G. et al. A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders. J. Inherit. Metab. Dis. 40, 261\u2013269 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1791_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0243-8","volume":"10","author":"M Tarailo-Graovac","year":"2015","unstructured":"Tarailo-Graovac, M. et al. The genotypic and phenotypic spectrum of PIGA deficiency. Orphanet J. Rare Dis. 10, 23 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"1791_CR61","doi-asserted-by":"crossref","unstructured":"Thevandavakkam, M. A. et al. Industrializing yeast as a drug repurposing platform for inherited metabolic diseases. bioRxiv, (2024).","DOI":"10.1101\/2024.08.23.609415"},{"key":"1791_CR62","doi-asserted-by":"publisher","first-page":"e100033","DOI":"10.1371\/journal.pone.0100033","volume":"9","author":"P Ranji","year":"2014","unstructured":"Ranji, P., Rauthan, M., Pitot, C. & Pilon, M. Loss of HMG-CoA reductase in C. elegans causes defects in protein prenylation and muscle mitochondria. PLoS ONE 9, e100033 (2014).","journal-title":"PLoS ONE"},{"key":"1791_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajmg.c.31347","volume":"160C","author":"MD Svoboda","year":"2012","unstructured":"Svoboda, M. D., Christie, J. M., Eroglu, Y., Freeman, K. A. & Steiner, R. D. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am. J. Med. Genet. C. Semin. Med. Genet. 160C, 285\u2013294 (2012).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"1791_CR64","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1074\/jbc.M110.165795","volume":"286","author":"MA Haeuptle","year":"2011","unstructured":"Haeuptle, M. A. et al. Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid. J. Biol. Chem. 286, 6085\u20136091 (2011).","journal-title":"J. Biol. Chem."},{"key":"1791_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109186","volume":"145","author":"MP Wilson","year":"2025","unstructured":"Wilson, M. P. & Morava, E. Dolichol synthesis defects: a cautionary note on the use of statins. Mol. Genet. Metab. 145, 109186 (2025).","journal-title":"Mol. Genet. Metab."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01791-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:02:23Z","timestamp":1791284543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01791-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01791-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"517"}}